XML 112 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Class A [Member]
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Restatement [Member]
Common Class A [Member]
Common Class B [Member]
Common Stock [Member]
Common Class B [Member]
Common Stock [Member]
Restatement [Member]
Common Class B [Member]
Common Stock [Member]
Common Stock [Member]
Restatement [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Restatement [Member]
AOCI Attributable to Parent [Member]
AOCI Attributable to Parent [Member]
Restatement [Member]
Retained Earnings [Member]
Retained Earnings [Member]
Restatement [Member]
Parent [Member]
Parent [Member]
Restatement [Member]
Noncontrolling Interest [Member]
Noncontrolling Interest [Member]
Restatement [Member]
Total
Restatement [Member]
Balances at Nov. 30, 2021     $ 216         $ 24,784       $ (5,000)           $ 20,000  
Balance, shares at Nov. 30, 2021     2,156,250                                
Net loss     $ 88,130     $ 25,357                         113,541  
Sale of Private Placement Units $ 47             4,737,453                 4,737,500  
Sale of Private Placement Units, shares 473,750                                      
Deferred underwriting compensation             (3,018,750)                 (3,018,750)  
Issuance of Shares at Initial Public Offering $ 863             86,249,137                 86,250,000  
Issuance of Shares at Initial Public Offering, shares 8,625,000                                      
Underwriter’s fees and other issuance costs             (2,200,348)                 (2,200,348)  
Remeasurement of Class A common stock to redemption value $ (863)             (87,111,637)                 (87,112,500)  
Remeasurement of Class A common stock to redemption value, shares (8,625,000)                                      
Class A Common Stock Measurement Adjustment             1,319,361       (1,319,361)            
Remeasurement of Class A common stock subject to possible redemption to redemption amount                   (821,712)           (821,712)  
Net income                   113,541           113,541  
Balances at Nov. 30, 2022 $ 47     $ 216               (2,032,532)           (2,032,269)  
Balance, shares at Nov. 30, 2022 473,750     2,156,250                                
Balances at Dec. 31, 2021             $ 10       $ (219,647)   1,819,304   $ 1,599,667     1,599,667  
Balance, shares at Dec. 31, 2021             10,000                          
Net loss                       (945,998)   (945,998)   4,836   (941,162) $ (941,162)
Foreign currency translation adjustment                     19,608     19,608       19,608  
Net income                                     (945,998) (945,998)
Balances at Dec. 31, 2022 $ 47     $ 216     $ 1 $ 10 9   (200,039) $ (200,039) (1,610,504) $ 873,306 (1,810,270) $ 673,277 4,836 $ 4,836 (1,805,434) 678,113
Balance, shares at Dec. 31, 2022 473,750     2,156,250     10,000 10,000                        
Balances at Nov. 30, 2022 $ 47     $ 216               (2,032,532)           (2,032,269)  
Balance, shares at Nov. 30, 2022 473,750     2,156,250                                
Net loss     $ 388,396     $ 160,477                         548,873  
Remeasurement of Class A common stock subject to possible redemption to redemption amount                   (668,842)           (668,842)  
Additional amount deposited into trust for loan extension                   (205,305)           (205,305)  
Net income                   548,873           548,873  
Balances at Nov. 30, 2023 $ 47     $ 216               (2,357,806)           (2,357,543)  
Balance, shares at Nov. 30, 2023 473,750     2,156,250                                
Balances at Dec. 31, 2022 $ 47     $ 216     $ 1 $ 10 9   (200,039) (200,039) (1,610,504) 873,306 (1,810,270) 673,277 4,836 4,836 (1,805,434) 678,113
Balance, shares at Dec. 31, 2022 473,750     2,156,250     10,000 10,000                        
Net loss               171,127   171,127   722   171,849  
Foreign currency translation adjustment             58,843     58,843       58,843  
Net income                                     171,127  
Balances at Mar. 31, 2023 $ 47     $ 216     $ 1   9   141,196   (1,439,377)   (1,580,300)   5,558   (1,574,742)  
Balance, shares at Mar. 31, 2023 473,750     2,156,250     10,000                          
Balances at Dec. 31, 2022 $ 47     $ 216     $ 1 $ 10 9   (200,039) (200,039) (1,610,504) 873,306 (1,810,270) 673,277 4,836 4,836 (1,805,434) 678,113
Balance, shares at Dec. 31, 2022 473,750     2,156,250     10,000 10,000                        
Net loss                         (1,654,391)   (1,654,391)   3,830 (1,650,561) (1,650,561)
Foreign currency translation adjustment                     2,999     2,999     2,999
Net income                                     (1,654,391)  
Balances at Dec. 31, 2023   $ 47     $ 216   $ 10 $ 1   $ 9 (197,040) (197,041) (781,085) (2,765,403) (978,115) (2,962,171) 8,666 8,666 (969,449) (2,953,505)
Balance, shares at Dec. 31, 2023   473,750     2,156,250   10,000 10,000                        
Balances at Nov. 30, 2023 $ 47     $ 216               (2,357,806)           (2,357,543)  
Balance, shares at Nov. 30, 2023 473,750     2,156,250                                
Balances at Dec. 31, 2023   $ 47     $ 216   $ 10 $ 1   9 (197,040) (197,041) (781,085) (2,765,403) (978,115) (2,962,171) 8,666 8,666 (969,449) (2,953,505)
Balance, shares at Dec. 31, 2023   473,750     2,156,250   10,000 10,000                        
Net loss                 (1,336,838)   (1,336,838)   319 (1,336,519) (1,336,519)
Foreign currency translation adjustment               86,818     86,818     86,818
Sale of Private Placement Units           15   1,509,375       1,509,390     1,509,390
Sale of Private Placement Units, shares             149,443                          
Issuance of Common Stock during Merger           1,344   (1,369)       (25)     (25)
Issuance of Common Stock during Merger, shares             13,433,858                          
Deferred underwriting compensation             (645,860)       (645,860)     (645,860)
Convert Common Stock Class A and B to Common Stock   47     (216)     263            
Convert Common Stock Class A and B to Common Stock, shares (473,750)     (2,156,250)     2,630,000                          
Revaluation for SHRG note receivable and warrants             216,188       216,188     216,188
Change in Non-Controlling Interest Ketomei                     $ 155,514   $ 155,514
Net income                                     (1,336,838)  
Balances at Mar. 31, 2024         $ 1,623   $ 1,078,343   $ (110,223)   $ (4,102,241)   $ (3,132,498)   $ 164,499   $ (2,967,999)  
Balance, shares at Mar. 31, 2024         16,223,301